Using Videos to Facilitate Advance Care Planning for Patients With Heart Failure (VIDEO-HF)

November 16, 2020 updated by: Angelo E. Volandes, MD, Massachusetts General Hospital
The purpose of this study is to compare the decision making of subjects with advanced CHF having a verbal discussion about goals of care compared to subjects using a video.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Aim #1: To compare the impact of the intervention on the distribution of end-of-life knowledge, decisional conflict, and preferences among 248 subjects with advanced heart failure randomly assigned to one of two ACP modalities: 1. a video visually depicting the goals of care along with a patient checklist (intervention, 124 subjects), or 2. usual care, i.e., verbal narrative (control, 124 subjects).

Hypothesis #1: Compared to subjects randomized to the verbal narrative group, subjects randomized to the video intervention will be significantly more likely to:

1a. Have more knowledge about their choices

1b. Have less decisional conflict about their decisions

1c. Opt for comfort care and less likely to choose life-prolonging measures

Aim #2: To compare stability of preferences over time (1, 3, and 6 months), concordance rate of preferences (preferences expressed vs. preferences documented in the medical record - both inpatient and outpatient records), and advance care planning discussions (as reported by the patient), among 248 subjects randomized to the video (N=124) vs. verbal narrative (N=124).

Hypothesis #2: Compared to subjects randomized to the verbal narrative group, subjects randomized to the video intervention will be significantly more likely to:

1a. Have more stable preferences over time

1b. Higher concordance rates

1c. Have had an advance care planning discussion

Aim #3: To compare quality of life, anxiety and depression, referral to hospice, place of death, after death bereavement (caregiver), and resource utilization after 6 months and 1 year (or death) among 248 subjects randomized to the video (N=124) vs. verbal narrative (N=124).

Hypothesis #3: Compared to subjects randomized to the verbal narrative group, subjects randomized to the video intervention will be significantly more likely to:

1a. Have a better quality of life (FACIT-Pal, FACIT-Sp-12)

1b. Have earlier referral to hospice in subjects who die

1d. Die at home or hospice (or inpatient hospice setting) in subjects who die

1e. Have better caregiver bereavement score (for caregiver subjects who die).

Study Type

Interventional

Enrollment (Anticipated)

248

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02114
        • Recruiting
        • Massachusetts General Hospital
        • Contact:
          • Angelo Volandes, MD
        • Principal Investigator:
          • Angelo Volandes, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. A diagnosis of advanced heart failure as defined by ALL THREE of the following:

    • New York Heart Association Class III or IV (NYHA III or IV) (III: marked limitation in activity due to symptoms, even during less-than-ordinary activity; IV: severe limitations, experiences symptoms while at rest).

    AND

    • Hospitalization for heart failure within the last six months. AND
    • Age greater than or equal to 65.
  2. Additionally ONE of the following must be met:

    • According to the attending physician's best judgment the patient's survival is limited to 2 years but may very well be less than 1 year (i.e. the physician would not be surprised if the patient died within one year from any cause) OR
    • Three heart failure hospitalizations in the last year OR
    • One of the following:

      • Two Systolic Blood Pressures < 90 within the last 6 months in the ambulatory setting
      • Na < 130 within the last 6 months
      • NTproBNP > 3,000
      • EGFR < 35
      • High diuretic use (160 mg po Lasix or 100 mg po torsemide or equivalent total daily dose)

Exclusion Criteria:

  • New patient
  • A transplant or mechanical circulatory support candidate
  • Major psychiatric illness as determined by the attending that would make this study inappropriate.
  • Any patient that has been excluded for transplant or mechanical circulatory support due to psychological or psychiatric co-morbidities.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control group
Verbal description of goals of care reflecting usual care
Experimental: Video Arm
Video intervention group
Video decision aid of the goals of care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
knowledge
Time Frame: 5 minutes after survey
knowledge of the goals of care for CHF
5 minutes after survey
preferences
Time Frame: 5 minutes after survey
preferences for goals of care
5 minutes after survey

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
decisional conflict
Time Frame: 5 minutes after survey
decisional conflict regarding decision making
5 minutes after survey
stability
Time Frame: 5 minutes after survey and then at 1, 3, and 6 months
stability of preferences for goals of care
5 minutes after survey and then at 1, 3, and 6 months
concordance of preferences
Time Frame: by the end of one year
concordance of stated preferences with documented preferences in the medical record
by the end of one year
advance care planning discussion
Time Frame: by 6 months
self reported completion of advance care planning discussion
by 6 months
quality of life
Time Frame: after 6 months
better quality of life using FACIT questionnaire after 6 months
after 6 months
referral to hospice
Time Frame: by one year
referral to hospice for patients who die
by one year
place of death
Time Frame: by one year
place of death for those patients that die
by one year
caregiver bereavement score
Time Frame: by one year
caregiver bereavement score for those subjects that die
by one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2012

Primary Completion (Actual)

April 1, 2014

Study Registration Dates

First Submitted

April 28, 2012

First Submitted That Met QC Criteria

April 28, 2012

First Posted (Estimate)

May 1, 2012

Study Record Updates

Last Update Posted (Actual)

November 17, 2020

Last Update Submitted That Met QC Criteria

November 16, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2012-P-000341
  • 1R01HL107268-01 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on CHF

Clinical Trials on Video decision aid

3
Subscribe